Apple will resume selling the Apple Watch Series 9 and Ultra 2 in the US, at least for now. The company had stopped selling the wearables because of an ongoing legal battle with health tech company Masimo over the blood oxygen detection feature in those watches.
The US International Trade Commission, the federal agency that handles trade-related mandates, previously issued an order that would prohibit Apple from importing the Series 9 and Ultra 2. The decision came after a US judge ruled in January that Apple had infringed on Masimo patents related to the technology used in Apple’s blood oxygen sensing system. The order was under presidential review until Dec. 25 and became final on Dec. 26 after US Trade Representative Katherine Tai decided not to reverse the ITC’s decision.
Apple received a temporary win Wednesday after an Appeals Court paused the ban, allowing Apple to resume selling the devices on Thursday. Apple says that the company expects the US Court of Appeals for the Federal Circuit to hear its motion as early as Jan. 15 regarding a stay that would last for the entire duration of the appeal.
Apple is immediately restarting sales of both watches, and both the Series 9 and Ultra 2 watches became available to purchase on Apple’s website Thursday. According to a Wednesday statement, Apple is also working on changes to the Apple Watch Series 9 and Apple Watch Ultra 2 in order to keep the devices on sale.
“Apple strongly disagrees with the ITC’s decision. In addition to the appeal at the US Court of Appeals for the Federal Circuit, Apple is vigorously pursuing legal and technical options to ensure that we can continue to provide consumers with Apple Watch Series 9 and Apple Watch Ultra 2, including having submitted a proposed redesigned Apple Watch Series 9 and Apple Watch Ultra 2 for US Customs approval,” Apple’s statement said.
According to Bloomberg, Apple has been working on software changes to the Apple Watch’s blood oxygen detection feature, and…
Read the full article here